3,4-methylenedioxyamphetamine has been researched along with Liver Neoplasms in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Liver Neoplasms: Tumors or cancer of the LIVER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Li, H | 1 |
Lan, H | 1 |
Zhang, M | 1 |
Zhao, F | 1 |
An, N | 1 |
Yi, C | 1 |
Henderson, MJ | 1 |
Zwerling, I | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Liver Neoplasms
Article | Year |
---|---|
TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Topics: 3,4-Methylenedioxyamphetamine; Carcinoma, Hepatocellular; Ferroptosis; Humans; Liver Neoplasms; Reac | 2023 |
Remembering Sophie.
Topics: Aged, 80 and over; Humans; Liver Neoplasms; Love; Nurse Practitioners; Nurse-Patient Relations; Term | 2006 |
A single intervention: a visit to the family.
Topics: Adolescent; Adult; Child; Colonic Neoplasms; Crisis Intervention; Family; Father-Child Relations; Fe | 1980 |